We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$2.4B
AUM Growth
-$764M
Cap. Flow
-$999M
Cap. Flow %
-41.57%
Top 10 Hldgs %
44.25%
Holding
367
New
126
Increased
77
Reduced
66
Closed
85

Top Buys

Rank Stock Value
1
TPST icon
Tempest Therapeutics
TPST
+$94.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$24M
3
AGN
Allergan plc
AGN
+$13.8M
4
ZGNX
Zogenix, Inc.
ZGNX
+$11.9M
5
MBLY
Mobileye N.V.
MBLY
+$8.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$42.1M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$27.4M
3
AZN icon
AstraZeneca
AZN
+$13.5M
4
GILD icon
Gilead Sciences
GILD
+$11.5M
5
ACHN
Achillion Pharmaceuticals
ACHN
+$11.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.65%
2 Healthcare 9.88%
3 Technology 0.55%
4 Energy 0.39%
5 Industrials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHPG
351
PUT
DELISTED
Shire pic
SHPG
– –
-183
Closed -$3.89M
MDVN
352
CALL
DELISTED
MEDIVATION, INC.
MDVN
– –
-1,410
Closed -$7.02M
AGN
353
CALL
DELISTED
Allergan Inc
AGN
– –
-1,500
Closed -$31.9M
RPRX
354
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-279,879
Closed -$2.5M
OXGN
355
DELISTED
OXIGENE INC COM
OXGN
– –
-782,674
Closed -$1.26M
CERE
356
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
– –
-27,825
Closed -$53K
11 12 13 14
15

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q1 2015 Portfolio in Review

As of Q1 2015, Sabby Management held 367 positions worth $2.4B, down 24% from $3.17B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sabby Management withdrew a net $999M in Q1 2015, closing 85 positions and reducing 66 holdings. Its most notable exit was Pfizer, an estimated $42.1M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Sabby Management opened a new position in Tempest Therapeutics worth $4.69M.

  • Sabby Management's largest Q1 2015 buy was Tempest Therapeutics: 709 shares worth $4.69M.
  • Sabby Management added most to Allergan plc in Q1 2015, an estimated $13.8M increase.
  • Sabby Management's biggest Q1 2015 reduction was Achillion Pharmaceuticals, cutting an estimated $11.1M.
  • Sabby Management fully exited Pfizer in Q1 2015, selling an estimated $42.1M.
  • Sabby Management's ten largest holdings make up 44% of its $2.4B portfolio in Q1 2015.
  • Sabby Management opened 126 new positions and closed 85 in Q1 2015.
  • Sabby Management's portfolio value fell 24% quarter-over-quarter to $2.4B.

Based on Sabby Management's 13F filing for Q1 2015, filed 15 May 2015.